Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

Five years of adjuvant tamoxifen therapy for estrogen receptor (ER) -positive breast cancer is more effective than 2 years of use. However, information on tamoxifen discontinuation is scanty. We sought to identify predictors of tamoxifen discontinuation among older women with breast cancer. Within s...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 26; no. 4; p. 549
Main Authors:	Owusu, Cynthia, Buist, Diana S M, Field, Terry S, Lash, Timothy L, Thwin, Soe Soe, Geiger, Ann M, Quinn, Virginia P, Frost, Floyd, Prout, Marianne, Yood, Marianne Ulcickas, Wei, Feifei, Silliman, Rebecca A
Format:	Journal Article
Language:	English
Published:	United States 01.02.2008
Subjects:	Aged Aged, 80 and over Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - pathology Female Humans Life Tables Lymphatic Metastasis Medical Records - standards Neoplasm Recurrence, Local - prevention & control Neoplasm Staging Patient Compliance - statistics & numerical data Receptors, Estrogen - metabolism Selective Estrogen Receptor Modulators - administration & dosage Tamoxifen - administration & dosage Treatment Outcome
ISSN:	1527-7755, 1527-7755
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!